Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Ocular Oncology and Treatments, Retinal and Macular Surgery, CNS Lymphoma Diagnosis and Treatment, and Brain Metastases and Treatment.
Characterization of Belantamab Mafodotin–Induced Corneal Changes in Patients With Multiple Myeloma
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
Ocular toxicities of fibroblast growth factor receptor inhibitors: A review
Treatment of Retinoblastoma: What Is the Latest and What Is the Future
Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression
Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing
Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma
Refractive Shifts and Changes in Corneal Curvature Associated With Antibody–Drug Conjugates
Immune Checkpoint Inhibitor-Associated Optic Neuritis
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition
Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival
Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds
<i>BRAF</i>, <i>NRAS</i>, and <i>GNAQ</i> Mutations in Conjunctival Melanocytic Nevi
GNAQ Mutations in Diffuse and Solitary Choroidal Hemangiomas
Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience
Clinical and Morphologic Characteristics of MEK Inhibitor–Associated Retinopathy
Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy
An international survey of classification and treatment choices for group D retinoblastoma
Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma
Growth of Uveal Melanoma following Intravitreal Bevacizumab
The Classification of Vitreous Seeds in Retinoblastoma and Response to Intravitreal Melphalan
Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC
Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma